•  
  •  
  •  
  •  

2025-10-02 01:47:05

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  VijayaDiagnosticCentre

Stock Report

  • Vijaya Diagnostic Centre Ltd reports consolidated PAT of Rs. 38.33 crores in Q1 FY2026
  • Vijaya Diagnostic Centre Ltd recommends final dividend of Rs. 2
  • Vijaya Diagnostic Centre Ltd Q4 FY2025 consolidated PAT slips QoQ to Rs. 34.63 crores
  • Vijaya Diagnostic Centre Ltd posts rise in Q2FY25 consolidated PAT to Rs. 41.93 crores
  • Vijaya Diagnostic Centre Ltd posts consolidated Q1FY25 profit of Rs. 31.34 crores
  • Merger of Medinova Diagnostic Services Limited with Vijaya Diagnostic Centre Limited
  • Vijaya Diagnostic Centre Ltd recommends dividend of Rs. 1
  • Vijaya Diagnostic Centre Ltd Q4FY24 consolidated profit climbs to Rs. 33.45 crores
  • Vijaya Diagnostic Centre Ltd Q3 FY24 consolidated profit down QoQ to Rs. 25.84 crores
  • Vijaya Diagnostic Centre Ltd to acquire P H Diagnostic Centre Pvt Ltd
  • Vijaya Diagnostic Centre Ltd Q1 FY2024 consolidated PAT at Rs. 26.20 crores
  • Vijaya Diagnostic Centre Ltd consolidated Q3FY23 profit drops to Rs. 16.36 crores
  • Vijaya Diagnostic Centre Ltd Q2 FY23 consolidated net profit up QoQ at Rs. 23.32 crores
  • Vijaya Diagnostic Centre Ltd Q1 FY2022-23 consolidated profit lower at Rs. 17.45 crores
  • Vijaya Diagnostic Centre Ltd Q4 FY2021-22 consolidated PAT down to Rs. 23.71 crores
  • Vijaya Diagnostic Centre Ltd Board approves Dividend of Rs. 1
  • Vijaya Diagnostic Centre posts consolidated PAT of Rs. 25.28 crores in Q3 FY2021-22

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024